NCT05863793

Brief Summary

Diabetic peripheral neuropathy (DPN) is the most common chronic complication of diabetes mellitus that has a considerable impact on quality of life, but there are few effective therapeutic strategies. The aim of this trial is to determine the efficacy and safety of manual acupuncture (MA) versus sham acupuncture (SA) for DPN.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
118

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2021

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

March 24, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 18, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

May 18, 2023

Status Verified

May 1, 2023

Enrollment Period

3.3 years

First QC Date

March 24, 2023

Last Update Submit

May 17, 2023

Conditions

Keywords

Diabetic Peripheral NeuropathyAcupuncture Treatment

Outcome Measures

Primary Outcomes (1)

  • Peroneal Motor Nerve Conduction Velocity

    Measurement by electromyography

    12 week

Secondary Outcomes (6)

  • Glycated hemoglobin (HbA1c)

    12 week

  • Fasting plasma glucose (FPG)

    12 week

  • 2-h postprandial blood glucose (2hPG)

    12 week

  • Michigan Neuropathy Screening Instrument (MNSI) score

    12 week

  • Quality of life (QoL)

    12 week

  • +1 more secondary outcomes

Study Arms (2)

Manual Acupuncture Group

EXPERIMENTAL

Treatment will be performed by licensed acupuncturists who have at least 5 years of experience in acupuncture. All the acupuncturists will be trained how to locate acupoints, puncture, and manipulate needles before trials.

Other: Acupuncture

Sham Acupuncture

SHAM COMPARATOR

The procedure and duration of treatment in the sham acupuncture group will be identical in the MA group except the needles are blunt tip and there will be no skin penetration and needle manipulation for De qi.

Other: Sham Acupuncture

Interventions

The obligatory acupoints include Zhongwan (CV12), bilateral Weiwanxiashu (EX-B3), bilateral Ganshu (BL18), bilateral Pishu (BL20), bilateral Shenshu (BL23), bilateral Zusanli (ST36), bilateral Yanglingquan (GB34), bilateral Sanyinjiao (SP6), bilateral Taixi (KI3), and Bafeng (EX-LE10). Additional acupoints Baxie (EX-UE9) will be added when patients' symptoms appear not only in the lower limbs but also in the upper limbs. After skin disinfection, disposable, stainless steel acupuncture needles will be inserted into the skin of acupoint (approximately 10-20 mm depth), and then manipulations of twirling, lifting, and thrusting will be performed on all needles for at least 10 s to reach De qi (a compositional sensation including soreness, numbness, distention, and heaviness), which is believed to be an essential component for acupuncture efficacy. Needles will be retained in these acupoints for 20 min.

Manual Acupuncture Group

Patients in the SA group will receive sham acupuncture. The procedure and duration of treatment in the SA group will be identical in the MA group except the needles are blunt tip and there will be no skin penetration and needle manipulation for De qi.

Sham Acupuncture

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Aged 18-75 years (either sex)
  • Symmetric and predominantly sensory, starting from the lower limbs distally and gradually spreading proximally in a glove-and-stocking distribution.
  • Ability to understand study procedures and willingness to comply with them for the entire period of study.
  • Written informed consent

You may not qualify if:

  • PN caused by conditions other than diabetes (e.g.,alcohol abuse, chemotherapy, hereditary causes, chronic inflammatory, or idiopathic PN)
  • Psychiatric illnesses other than mild depression.
  • Severe or unstable cardiovascular, liver, kidney, respiratory, or hematological disorders.
  • Received acupuncture treatment in the last 3 months.
  • Pregnant or lactating women.
  • Research unit personnel directly related to the study and their immediate family members.
  • Incapable of giving informed consent or following the study instructions due to language disturbances, serious cognitive deficits, or lack of time.
  • Currently participating in other clinical trials.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

LongHua Hospital Shanghai University of Traditional Chinese Medicine

Shanghai, Shanghai Municipality, 200032, China

RECRUITING

MeSH Terms

Interventions

Acupuncture Therapy

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Jian Pei

    Shanghai University of Traditional Chinese Medicine

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 24, 2023

First Posted

May 18, 2023

Study Start

September 1, 2021

Primary Completion

January 1, 2025

Study Completion

January 1, 2025

Last Updated

May 18, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations